transgene Logo (WIPO, 07/21/2020)
WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark transgene was filed as Figurative mark on 07/21/2020 at the World Intellectual Property Organization.
Logodesign (Wiener Klassifikation)
#Segments or sectors of circles or ellipses #Colours #Segments of circles or ellipses (except 26.2.7) #Joined or intersecting segments or sectors of circles or ellipses #Two predominant colours
| Trademark form | Figurative mark |
| File reference | 1550991 |
| Countries | 
|
| Base trademark |
No. 4625500,
February 19, 2020
|
| Application date | July 21, 2020 |
| Expiration date | July 21, 2030 |
Trademark owner
Parc d'Innovation,
Boulevard Gonthier d'Andernach
FR
Boulevard Gonthier d'Andernach
FR
Trademark representatives
10 rue Jacques Kablé
F-67080 STRASBOURG CEDEX
FR
goods and services
05
Medicines; anti-cancer medicines; cancer treatment
compounds; pharmaceutical preparations and substances for
cancer treatment and/or prevention; immunotherapeutic
products and agents in oncology; immunotherapeutic products
and agents for bacterial infections; customized
immunotherapy products; products to stimulate and modulate
the immune system; oncolytic viruses; medicinal
preparations and pharmaceutical preparations for the
treatment of infectious or genetic diseases; pharmaceutical
preparations for use in chemotherapy; chemotherapeutic
agents; Pharmaceutical substances and preparations used in
oncology; vaccines; cancer vaccines; therapeutic vaccines
in oncology or genetics; viral vaccines; tumor antigens;
viral antigens; vaccine adjuvant; Chemicals and
biochemicals for medical and clinical use; agents and
reagents for medical or clinical use; chemical or
biochemical test kits; reagents for medical and clinical
use comprising preparations, agents and reagents;
Pharmaceutical products and substances; medical
preparations; stem cells for medical use; clinical medical
reagents; cytostatic medicines for medical use; reagents
for genetic testing in medicine; preparations for detecting
genetic predispositions for medical use
42
Scientific research for medical purposes in the field of
cancerous and infectious diseases; research and development
of vaccines and medicines; research and development of
therapeutic vaccines and immunotherapy products in oncology;
research and development of oncolytic viruses; research and
development in the field of biotechnology and genetics;
analyses in the field of molecular biology; scientific
research and studies; biological, clinical and medical
research services; analyses in the fields of biology,
genetics or pharmacology; scientific and technical project
studies; scientific studies; scientific research services;
research in the field of pharmacogenetics; research and
professional consultations in the scientific and medical
field and especially in genetics, oncology, biology or
pharmacology; design and development of software and
computer databases in the field of scientific and medical
research; design and development of software and computer
databases in the field of biological, genetic and medical
analysis; writing computer programs for biotechnological,
genetic and medical applications; development and testing of
methods, algorithms and computer software, especially
predictive software, in the medical field; research, design
and development in the field of diagnostic preparations for
cancer patients; research, design and development of
diagnostic preparations for patients in the field of
infectious diseases
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| July 7, 2022 | 2022/28 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| September 3, 2021 | 2021/36 Gaz | JP | Rejection |
| August 13, 2021 | 2021/33 Gaz | CH | Rejection |
| March 9, 2021 | 2021/10 Gaz | GB | Rejection |
| February 8, 2021 | 2021/6 Gaz | EM | Rejection |
| July 21, 2020 | 2020/36 Gaz | FR | Registration |
ID: 141550991